Li, J.; Chen, G.; Meng, Z.; Wu, Z.; Gan, H.; Zhu, X.; Han, P.; Liu, T.; Wang, F.; Gu, R.;
et al. Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection. Molecules 2022, 27, 2745.
https://doi.org/10.3390/molecules27092745
AMA Style
Li J, Chen G, Meng Z, Wu Z, Gan H, Zhu X, Han P, Liu T, Wang F, Gu R,
et al. Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection. Molecules. 2022; 27(9):2745.
https://doi.org/10.3390/molecules27092745
Chicago/Turabian Style
Li, Jian, Guangrui Chen, Zhiyun Meng, Zhuona Wu, Hui Gan, Xiaoxia Zhu, Peng Han, Taoyun Liu, Fanjun Wang, Ruolan Gu,
and et al. 2022. "Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection" Molecules 27, no. 9: 2745.
https://doi.org/10.3390/molecules27092745
APA Style
Li, J., Chen, G., Meng, Z., Wu, Z., Gan, H., Zhu, X., Han, P., Liu, T., Wang, F., Gu, R., & Dou, G.
(2022). Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection. Molecules, 27(9), 2745.
https://doi.org/10.3390/molecules27092745
